Literature DB >> 3274085

A rearranged transforming gene, tre, is made up of human sequences derived from chromosome regions 5q, 17q and 18q.

K Huebner1, L A Cannizzaro, T Nakamura, J Hillova, R Mariage-Samson, F Hecht, M Hill, C M Croce.   

Abstract

The transfection recombinant transforming gene, tre, originated from discontinuous human genetic elements after transfection of NIH3T3 cells with genomic DNA from a Ewing's sarcoma cell line. Probes for the three normally discontinuous human elements involved in the transfection recombinant were subcloned and used in conjunction with a panel of rodent-human hybrid cells to determine their normal location in the human genome. The leftmost (5') element derives from the long arm of chromosome 5 (5q); the internal fragment derives from human chromosome 18 proximal to the bcl-2 gene; and the rightmost (3') element derives from the long arm of chromosome 17 (17q) distal to an acute leukemia breakpoint at 17q21. In situ hybridization of the same probes to human metaphase chromosomes confirmed localization of these sequences to regions 5q23----q31, 18q12, and 17q12----q22.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3274085

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system.

Authors:  R G Collum; P E Fisher; M Datta; S Mellis; C Thiele; K Huebner; C M Croce; M A Israel; T Theil; T Moroy
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

2.  Twenty-seven nonoverlapping zinc finger cDNAs from human T cells map to nine different chromosomes with apparent clustering.

Authors:  K Huebner; T Druck; C M Croce; H J Thiesen
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

3.  Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study.

Authors:  H J Decker; L A Cannizzaro; M J Mendez; S P Leong; H Bixenman; C Berger; A A Sandberg
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

4.  The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2.

Authors:  C Martinerie; L A Cannizzaro; C M Croce; K Huebner; S Katzav; M Barbacid
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

5.  UBPY: a growth-regulated human ubiquitin isopeptidase.

Authors:  S Naviglio; C Mattecucci; B Matoskova; T Nagase; N Nomura; P P Di Fiore; G F Draetta
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  Order of genes on human chromosome 5q with respect to 5q interstitial deletions.

Authors:  K Huebner; L Nagarajan; E Besa; E Angert; B J Lange; L A Cannizzaro; H van den Berghe; D Santoli; J Finan; C M Croce
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

Review 7.  Human-specific genes may offer a unique window into human cell signaling.

Authors:  Philip D Stahl; Marisa J Wainszelbaum
Journal:  Sci Signal       Date:  2009-09-22       Impact factor: 8.192

8.  Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.

Authors:  C E Gauwerky; K Huebner; M Isobe; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is regulated by protein palmitoylation.

Authors:  Chen Kong; Jeffrey J Lange; Dmitri Samovski; Xiong Su; Jialiu Liu; Sinju Sundaresan; Philip D Stahl
Journal:  Biochem Biophys Res Commun       Date:  2013-04-08       Impact factor: 3.575

10.  Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase.

Authors:  Chen Kong; Dmitri Samovski; Priya Srikanth; Marisa J Wainszelbaum; Audra J Charron; Jialiu Liu; Jeffrey J Lange; Pin-I Chen; Zhen-Qiang Pan; Xiong Su; Philip D Stahl
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.